If you are wondering whether Medtronic is offering fair value at its current price, you are not alone. This article focuses ...

Anteris Technologies says Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve ...

Medtronic (MDT) is back on investors’ radar after recent share price moves, with the stock closing at $98.60 on Tuesday. That ...

Valued at a market cap of $126.4 billion, Medtronic plc (MDT) develops, manufactures, and sells device-based medical ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers that could lift earnings and investor returns over the next few years.

Investors traded out of the company the previous day following its latest earnings release. The stock came roaring back on Hump Day, however. The shares benefited from a clutch of analyst price target ...

Medtronic (NYSE:MDT – Free Report) had its target price boosted by Argus from $105.00 to $115.00 in a research note published on Tuesday morning, MarketBeat reports. They currently have a buy rating ...

In addition, pursuant to a stock purchase agreement, dated January Anteris has agreed to sell to Medtronic plc (through a wholly owned subsidiary) in a private placement exempt from the registration ...